VANCOUVER, Jan. 7 /CNW/ - Ondine Biopharma Corporation (the "Company" or "Ondine", TSX: OBP; AIM: OBP) announces a reorganization to its senior management team reflecting the Company's focus on the development of its photodisinfection product pipeline. Dr. Cale Street has been appointed Vice-President of Research of Ondine's wholly-owned subsidiary, Ondine Research Laboratories, Inc. ("ORL"); located at the Company's research facilities in Bothell, Washington. Mr. Thomas Dawson, who continues as an officer of ORL, has been appointed Chief Operating Officer of the Company. Dr. Nicolas Loebel, who continues as an officer of ORL and as Chief Technology Officer of the Company, has been appointed President of the Company.

Carolyn Cross, who continues to hold the title of Chief Executive Officer of the Company, has been appointed Chairman of Ondine's Board of Directors, replacing Mr. Pierre Leduc who has resigned his positions of Executive Chairman and a Director of the Company effective January 6, 2009. Ondine wishes to thank Mr. Leduc for his contributions to the Company over the past 4 years and wishes him every success in his future endeavours.